Literature DB >> 15081453

A trial of omega-3 fatty acids for prevention of hypertension.

Rachel S Dokholyan1, Christine M Albert, Lawrence J Appel, Nancy R Cook, Paul Whelton, Charles H Hennekens.   

Abstract

Although omega-3 polyunsaturated fatty acid supplements reduce blood pressure (BP), the typical doses cause untoward side effects. A novel fatty acid supplement was tested in a randomized trial of patients with high normal diastolic BP. The novel fatty acid supplement did not significantly reduce BP in patients with high normal diastolic blood pressure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15081453     DOI: 10.1016/j.amjcard.2004.01.013

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Long-chain omega-3 fatty acids and blood pressure.

Authors:  James C Liu; Sarah M Conklin; Stephen B Manuck; Jeffrey K Yao; Matthew F Muldoon
Journal:  Am J Hypertens       Date:  2011-07-14       Impact factor: 2.689

2.  Association of circulating saturated fatty acids with the risk of pregnancy-induced hypertension: a nested case-control study.

Authors:  Xinping Li; Yichao Huang; Wenxin Zhang; Chenhui Yang; Weijie Su; Yi Wu; Xiaomei Chen; Aifen Zhou; Xia Huo; Wei Xia; Shunqing Xu; Da Chen; Yuanyuan Li
Journal:  Hypertens Res       Date:  2020-01-09       Impact factor: 3.872

3.  Effects of Rosuvastatin Alone or in Combination with Omega-3 Fatty Acid on Adiponectin Levels and Cardiometabolic Profile.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb
Journal:  J Basic Clin Pharm       Date:  2016-12

4.  Screening of microbial lipases and evalutaion of their potential to produce glycerides with high gamma linolenic acid concentration.

Authors:  Patricia B L Fregolente; Leonardo V Fregolente; Maria R W Maciel; Patricia O Carvalho
Journal:  Braz J Microbiol       Date:  2009-12-01       Impact factor: 2.476

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.